2024-10-102024-10-102010-08-011304-9054https://hdl.handle.net/11452/46223Increased worldwide incidences of retinopathy of prematurity have been noted due to the recent devolepments in newborn care and increased availability of newborn intensive care units. Increased number of Newborn Intensive Care Units leads to survive of increased number of immature babies, therefore, there is an increased number of premature infants to be screened and eyes to be treated. The aim of this review is to evaluate the current improvements and treatment modalities in retinopathy of prematurity. Introduction of anti angiogenetic agents for intraocular injection with or alternative to laser photocoagulation and criotherapy for treatment may broaden our view in the management of retinopathy of prematurity.eninfo:eu-repo/semantics/closedAccessEndothelial growth-factorLaser photocoagulationFactor-iRetinal neovascularizationStage-3 retinopathyVisual-acuityVitrectomyManagementInfantsOxygenRetinopathy of prematurityAntiangiogenicTreatmentScience & technologyLife sciences & biomedicinePediatricsReview000422256600007727782